Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Contract Research Organization providing Phase I-IV core development 
services for drug, biologic, and device programs
News and Upcoming Events

News Releases

2015

Mark Metzner and Dr. Charles Pierce to Present Best Practices in Patient Recruitment at ACRP

Medpace Expands Leadership in Early Phase and Neuroscience Drug Development - Dr. Richard D. Scheyer Joins Medpace as Vice President Medical Affairs

Eric Humes to speak at the 31st SQA Annual Quality Meeting on the Cost of Non-Compliance in Clinical Studies

Medpace named Top Ten CRO in 2015 CenterWatch Investigative Site Survey

Medpace VP of Regulatory Affairs, Dr. Steven B. Johnson to present at Partnerships in Clinical Trials

Medpace Medical Device Hosting Workshops as Part of its Complex Medical Devices Series

Medpace Launches “The Power of Giving” Campaign - Program aligns with therapeutically-focused clinical research model

Dr. Franklin O. Smith Keynote Speaker at Leukemia and Lymphoma Society Program: “No Progress without Clinical Trials”

Dr. Evan Stein to Present on PCSK9 Inhibitors at ASCPT

Medpace to Present on Risk-Based Monitoring at Upcoming SCOPE Meeting

Medpace's Michelle Petersen to present on Rare Disease Study Conduct at Outsourcing in Clinical Trials West Coast

Medpace Supports Madisonville Revitalization

Dr. James J. Vornov Joins Medpace as Vice President, Medical Affairs

Dr. Markus Heep Joins Medpace as Medical Director for Infectious Disease

2014

Medpace expands Executive Management Team, adding Kurt A. Brykman as COO, CRO Operations; and Jesse Geiger, COO, Laboratory Operations and CFO

Medpace to Present Webinar - Understanding Real World Evidence: A Registry Study Perspective

Medpace Hosting Workshops: Connecting the Dots for Accelerated Rare Disease Studies

Dr. Anibal Ruben Calmaggi Joins Medpace as Senior Medical Director for Infectious Disease

Medpace Hosting Medical Device Workshops to Provide Best Practices for Conducting Global Trials

Medpace Salutes Julie J. Hopkins, Cincinnati Leukemia & Lymphoma Society Woman of the Year 2014

Medpace expands therapeutic leadership in Oncology with the addition of Franklin O. Smith, III, MD, as Vice President, Medical Affairs

Medpace expands offices in the UK, supporting rapid growth in European Clinical Teams

David Klein, MD, PhD joins Medpace as a Medical Director, Further Strengthening Global Endocrinology and Pediatric Drug Development Capabilities

Medpace Quality Assurance Executive Joins Industry Experts to conduct DIA Training in Beijing

Medpace Reference Laboratories (MRL) opens central laboratory in Singapore

Medpace Strengthens Cardiovascular, Pediatric, and Rare Disease Drug and Medical Device Development Capabilities: Dr. Pirouz Shamszad MD, FAAP joins Medpace as a Medical Director

NephroGenex picks Medpace for kidney disease Phase III

Medpace to Present at Partnerships in Clinical Trials 2014: Argos Therapeutics and Medpace present lessons learned from an oncology rescue study

Cinven invests in Medpace, citing strong growth drivers in the CRO market

Medpace to Present at Outsourcing Clinical Trials – West Coast

Medpace Strengthens Global Oncology Drug Development Capabilities - Dr. Jamal Gasmi joins Medpace as Medical Director

Cardiac Safety Research Consortium (CSRC) Releases Cardiovascular Case Report Forms for use in Non Cardiovascular Clinical Trials